PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
65.30%
Some net income increase while CRK is negative at -153.61%. John Neff would see a short-term edge over the struggling competitor.
-17.65%
Negative yoy D&A while CRK is 108.73%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-114.24%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-100.00%
Negative yoy SBC while CRK is 12.89%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
219.33%
Less working capital growth vs. CRK's 2162.84%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
-13.33%
Both yoy AR lines negative, with CRK at -113.13%. Martin Whitman would suspect an overall sector lean approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
219.33%
Growth well above CRK's 213.58%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
321.37%
Operating cash flow growth above 1.5x CRK's 6.81%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-39.29%
Both yoy lines negative, with CRK at -9.26%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
442.86%
Acquisition growth of 442.86% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
229.04%
Purchases growth of 229.04% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-73.02%
We reduce yoy sales while CRK is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-39.29%
We reduce yoy other investing while CRK is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
52.61%
We have mild expansions while CRK is negative at -8.95%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-383.33%
We cut debt repayment yoy while CRK is 99.70%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.